Patents by Inventor Shunsuke Tsujimoto

Shunsuke Tsujimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240329590
    Abstract: An image forming system includes an image forming apparatus including an AC-DC converter and a main board, and a sub board having a sub connector connectable with a main connector of the main board. When the sub board is not connected with the main board, a main DC-DC converter on the main board converts a DC voltage from the AC-DC converter into a first DC voltage and output the first DC voltage to a circuit element for image formation. When the sub board is connected with the main board, the AC-DC converter outputs the DC voltage to a sub DC-DC converter on the sub board via the main connector and the sub connector, and the sub DC-DC converter converts the DC voltage from the AC-DC converter into a second DC voltage and output the second DC voltage to the circuit element via the sub connector and the main connector.
    Type: Application
    Filed: March 28, 2024
    Publication date: October 3, 2024
    Applicant: BROTHER KOGYO KABUSHIKI KAISHA
    Inventors: Yoshiyuki TSUJIMOTO, Nobuyuki TANAKA, Toshinori ARAKI, Seiya SATO, Shunsuke AIBA, Yutaro KUGE
  • Publication number: 20190374515
    Abstract: The present invention pertains to a therapeutic drug or prophylactic drug for diabetic nephropathy, said drug comprising a compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: November 27, 2017
    Publication date: December 12, 2019
    Applicant: TEIJIN PHARMA LIMITED
    Inventors: Takashi SHIRAKURA, Shunsuke TSUJIMOTO, Yoshiki TSUBOSAKA
  • Publication number: 20150005506
    Abstract: The purpose of the present invention is to provide a novel therapeutic agent or a novel prophylactic agent for diseases associated with abnormal glucose metabolism. The present invention is a therapeutic agent or a prophylactic agent for diseases associated with abnormal glucose metabolism, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: January 25, 2013
    Publication date: January 1, 2015
    Applicants: NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY, TEIJIN PHARMA LIMITED
    Inventors: Ichiro Hisatome, Shunsuke Tsujimoto, Takashi Shirakura, Shinya Hiramitsu